Caplacizumab Model-Based Dosing Recommendations In Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura

PAGE 29 (2021) Abstr 9653.

Sou T, Hansson E, Bergstrand M, Callewaert F, Sousa RP, Sargentini L